Citations

Mayo Clinic

Showing 10 of 108572 citations.

Abstract 15714: Racial Disparities in Major Adverse Cardiac and Cerebrovascular Events Among Young Women (Aged 18-44) Admitted in Rural Settings: “A Comprehensive National Inpatient Analysis 2019”
Tera, Chenna Reddy, Vatsavayi, Priyanka , Jitta, Sahas Reddy , Maramreddy, Supriya, Krishnamurthy, Shobana, Tripuraneni, Sridevi, Pasnoor, Diksha Sanjana , Jala, Saisree Reddy Adla, Reddy, Medha, Dasari, Utheja, Farooq, Aisha, jammula, kavya, Maramreddy, Supriya, Tripuraneni, Sridevi, JAMMULA, KAVYA, Desai, Rupak

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.15714 Get It

Background: Limited research has focused on the rising incidence of major adverse cardiac and cerebrovascular events (MACCE) among young women (aged 18-44) with at least one traditional cardiovascular disease risk factor (CVD), especially in rural hospital settings. We aimed to address this research gap by providing insights into the burden of CVD in this population. Methods: Using data from the National Inpatient Sample (2019), we identified young women (aged 18-44) with at least one cardiovascular risk factor admitted to rural hospitals. Baseline demographics, comorbidities, and outcomes were assessed, including MACCE and all-cause mortality. Multivariable logistic regression was performed, adjusting for age, race, income, and comorbidities. Results: Among 179,410 young women, MACCE occurred in 2,455 individuals (1.4%), with varying rates among racial groups: whites (1.2%), blacks (2.4%), Hispanics (1.3%), Asian or Pacific Islanders (API) (2%), Native Americans (NA) (1.6%), and others (1%). All-cause mortality was observed in 385 women (0.2%), with rates of 0.2% for whites and 0.4% for blacks. Blacks had twice the event rates of MACCE, and all-cause mortality compared to whites. Comorbidities and substance abuse were associated with MACCE (P<0.001). In higher-income households, multivariable analysis adjusted for confounders revealed significantly higher odds of MACCE in blacks (OR 1.23, 95% CI 0.11-14.08), API (OR 4.48, 95% CI 1.06-18.93), and NA (OR 10.22, 95% CI 1.03-101.50) compared to whites. In contrast, mortality rates were lower for Hispanics than whites (OR 0.24, 95% CI 0.02-3.80) (all p < 0.001) (Table 1). Conclusion: In higher-income households, greater odds of MACCE were noted among blacks, API, and NA compared to whites. Future research should focus on understanding factors contributing to these disparities and developing interventions to prioritize equitable healthcare access for rural women across diverse ethnic and income classes.
Abstract 15706: Common- and Rare-Variant Genetic Architecture of Heart Failure Across the Allele Frequency Spectrum
Depaolo, John, Aragam, Krishna G. , Biddinger, Kiran J., Khan, Atlas , Day, Sharlene M. , McNally, Elizabeth M., Owens, Anjali , Levin, Michael G. , Lee, David S. , DePaolo, John S. , Conery, Mitchell , Dikilitas, Ozan , Puckelwartz, Megan J. , Reza, Nosheen , Satterfield, Benjamin A. , Arany, Zoltan Pierre , Cappola, Thomas P. , Joseph, Jacob , Voight, Benjamin F. , Damrauer, Scott M

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.15706 Get It

Background: Heart failure (HF) is a complex trait influenced by environmental and genetic factors. Genome-wide association studies (GWAS) have found common genetic variants associated with HF risk, but the extent that common and rare variants explain risk and implicate similar genes and pathways in HF remains less understood. Methods: For common variants, we meta-analyze existing GWAS of all-cause HF with data from the Million Veteran Program, including 207,346 individuals with HF and 2,151,210 without in diverse populations. We examine rare coding variants in the Penn Medicine BioBank (PMBB) using gene-collapsing association studies and burden heritability regression. We test for an interaction between a polygenic risk score (PRS) based on our GWAS meta-analysis and truncating variants in TTN (TTNtv). Results: GWAS meta-analysis identified 176 risk loci (146 previously unreported), implicating known risk factors for HF and genes involved in cardiac development. New signals at GIPR/ GLP1R highlight potential contributions of dysregulated glucose homeostasis and metabolism in HF. Gene collapsing studies identified associations between HF and rare loss-of-function variants in TTN (OR 2.94, 95% CI 2.43-3.56) and MYBPC3 (OR 7.71, 95% CI 3.97-14.97) at exome-wide significance. HF heritability mediated through common variants (4.5%) was significantly higher than for rare variants (1.8%), but rare variant heritability was further enriched in cardiomyopathy genes compared to common variants (27-fold vs. 3.4-fold). We found a significant interaction between a new multi-ancestry HF-associated PRS (AUC 0.72, 95% CI 0.72-0.73) and TTNtv carrier status (interaction OR 1.32, 95% CI 1.06-1.64). Conclusions: Common and rare variants contribute to HF heritability. Common variant HF heritability is highly polygenic, while rare variant burden heritability appears more concentrated in core cardiomyopathy genes. HF risk conferred by TTNtv carrier status is further increased by an individual’s polygenic contribution. Our results support the continued inclusion of cardiomyopathy genes in rare-variant genetic testing panels for HF but suggest a meaningful polygenic component to HF exists that is not currently captured by clinical genetic testing.
Abstract 15685: Artificial Intelligence Analysis of Facial Photographs for the Prediction of Abdominal Aortic Aneurysms
Arruda-Olson, Adelaide A, Kaggal, Vinod C. , Prodduturi, Naresh, Liedl, David , Wennberg, Paul W. , Rooke, Thom W. , Murphy, Seán , Houghton, Damon E. , Casanegra, Ana I. , McBane, Robert D.

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.15685 Get It

Introduction: Predictive algorithms using multiple clinical variables can identify patients at higher risk for abdominal aortic aneurysms (AAA), however they are cumbersome and cannot used directly by patients. A simple, cheap, noninvasive, and readily available (virtual) screening tool for identification of AAA could aid in screening algorithms. Aims: We sought to determine if a machine learning algorithm could predict the presence of an AAA by using a image of the face Methods: Diagnostic imaging studies were extracted from the electronic health record (EHR) from 5/7/2018 through 1/1/2023 and analyzed by a natural language processing algorithm previously validated to identify abdominal aortic aneurysms. Patient EHR profile pictures were extracted and matched to imaging studies. Various deep neural network (DNN) architectures were explored, all trained as classifiers on the face images along with clinical variables to predict clinical outcomes. All models used were CNNs with an EfficientNet architecture. Model performance was evaluated by standard metrics such as the area under the curve (AUC), specificities (Sp), and sensitivities (Sn). All performance metrics reported results from the test subset of the primary dataset and did not contain any observations considered during training. Results: A total of 5522 patients with facial images and AAA diagnostic studies were analyzed, among whom 1314 (23.8%) had a AAA. The optimal model had an AUC of 0.72 (Sn 0.44, Sp 0.83) for predicting AAA and remained similar in women (AUC 0.7), men (AUC 0.65), age >65 (AUC 0.63), and age <=65 (AUC 0.72) (Table). Conclusions: Using only an image of a patients face, the presence of an AAA could be identified with moderate performance in men, women, and in those less than 65. The model’s performance in demographics not typically screened for AAA may allow for targeted screening programs in these groups.
Abstract 15632: Warfarin Dose Management Using Offline Deep Reinforcement Learning
Ji, Hannah , Gill, Matthew F, Draper, Evan , Liedl, David , Hodge, David O. , Gill, Matthew, Houghton, Damon E. , Casanegra, Ana I.

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.15632 Get It

Introduction: Warfarin is a commonly prescribed anticoagulant for treating atrial fibrillation, mechanical valves, and venous thromboembolism. Warfarin dose management remains challenging due to dosing variability between patients and warfarin’s narrow therapeutic window. Time in therapeutic range (TTR) is critical to warfarin’s safety and efficacy, but TTR typically remains low (40-50%) in community practices. Specialized anticoagulation clinics and protocolized approaches can increase TTR but have great administrative burdens and health care costs. Aim: To develop standardized optimal warfarin dose decision support using a machine learning model based on time series anticoagulation data and patient demographic characteristics Methods: The dataset included 12,497 warfarin patients monitored in the anticoagulation tracker of electronic medical records across the Mayo Clinic Enterprise. The dataset contained time series anticoagulation data (warfarin dose, INR, INR target range) and patient demographic characteristics. We implemented an offline deep reinforcement learning model (DRL) to predict the cumulative warfarin dose for the days until the next INR test based on a patient’s historical anticoagulation data. Prior approaches utilized traditional supervised learning methods such as regression or Long Short Term Memory (LSTM) neural networks to approximate a function mimicking the behavior of the training data. On the other hand, DRL learned an optimal dosing policy through continuous interaction and feedback from the training data. The key advantage of DRL is the model can learn to behave differently (and potentially better) for suboptimal clinical states in the data such as overdosing or underdosing. To evaluate the DRL model we compared the predicted warfarin doses with the physician-prescribed doses Results: DRL model’s prediction accuracy was 96.96%, outperforming our implementation of a baseline LSTM model with a prediction accuracy of 70.58%. Further evaluation of the DRL model indicated that the model correctly adjusted the warfarin dose at time steps when patients had out-of-range INRs. Conclusions: Offline deep reinforcement learning demonstrates potential in supporting warfarin dose management to maximize TTR.
Abstract 15584: Artificial Intelligence-Guided Screening for Atrial Fibrillation Detection Among Patients With Different Socioeconomic Status
Kalinoski-DuBose, Victoria , Deng, Yihong, Graff‐Radford, Jonathan , Yao, Xiaoxi , Noseworthy, Peter A. , Deng, Yihong , Attia, Zachi I. , López-Jiménez, Francisco , Gersh, Bernard J.

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.15584 Get It

Introduction: Recently, an artificial intelligence (AI) algorithm was validated for identifying ECG signatures of atrial fibrillation (AF) risk during normal sinus rhythm. Traditionally, socioeconomically disadvantaged populations are less likely to receive novel or guideline-recommended treatments, and have high chronic disease burden, including cardiovascular diseases. There have also been concerns about new technologies creating a digital divide, worsening existing health disparities. Hypothesis: An AI algorithm will detect AF risk unequally across patients with different levels of social determinants of health (SDOH). Methods: The initial prospective, non-randomized, interventional study leveraged EHR and digital technologies to prospectively enroll 1004 patients with a broad range of AI-ECG risks of AF, who received continuous cardiac rhythm monitoring for up to 30 days. The Area Deprivation Index (ADI) was used as a composite measure of SDOH which is comprised of indicators spanning four domains: income, education, employment, and house quality. 904 intervention patients linked to the ADI data were matched to 904 real-world control patients derived from eligible but unenrolled patients. Those with ADI under 33% were defined as having better SODH; and patients with ADI above 33% were defined as having worse SODH. Results: Median age was 74 years and 38% were women. After matching, the intervention and control arms were balanced in all baseline characteristics, including HF, HTN, diabetes, stroke, CAD and ADI. A hazard ratio of 3.11 (P<0.001) was computed when comparing intervention to control for primary AF diagnosis outcome. In patients with worse SDOH, the intervention increased AF detection from 2.6% to 8.8% (HR 3.63 [2.09, 6.32]); in the better SDOH, the intervention increased AF detection from 3.9% to 9.3% (2.41 [1.23, 4.74]). Conclusions: An AI-guided AF screening program increased the detection of AF in both patients with better or worse SDOH. The current study validates the use of AI in historically disadvantaged populations displaying the possibility for broad implementation with decreased possibility of perpetuating disparities.
Abstract 15559: Mortality Risk Stratification Using Artificial Intelligence Augmented Prediction of Serum Potassium in Cardiac Intensive Care Unit Patients
Heinrich, Christopher, Friedman, Paul A. , Heinrich, Christopher , Harmon, David , Dillon, John , Kashani, Kianoush , Attia, Zachi I. , Jentzer, Jacob C.

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.15559 Get It

Introduction: Hyperkalemia has been associated with increased mortality in cardiac intensive care unit (CICU) patients. An artificial intelligence (AI) augmented electrocardiogram (ECG) can predict hyperkalemia, and other AI-ECG algorithms have predicted mortality in CICU patients. Hypothesis: We hypothesized that the AI-ECG hyperkalemia algorithm could stratify mortality risk beyond the serum potassium measurement. Methods: We included 11 234 unique Mayo Clinic CICU patients admitted from 2007 to 2018 who had both a 12 lead ECG and blood potassium (K) level obtained at admission with K>=5 mEq/L defining hyperkalemia. ECGs underwent AI evaluation for probability of hyperkalemia (probability >=0.5 defined as positive). Hospital mortality was analyzed using logistic regression and survival to one year was estimated using Kaplan-Meier and Cox analysis. Results: The mean age was 70 years, 37.8% were females, and 92.4% were white. Chronic kidney disease was present in 20%. The mean K value was 4.2 mEq/L, and 13% (n=1460) had hyperkalemia. AI-ECG predicted hyperkalemia in 34% (n=3820). In-hospital mortality was higher in patients with laboratory and/or AI-ECG hyperkalemia, and these patients had lower survival out to 1 year. Mortality was lowest in patients with normal K and negative AI-ECG and highest in patients with both laboratory-confirmed hyperkalemia and AI-ECG predicted hyperkalemia. Patients with isolated laboratory hyperkalemia (false-negative AI-ECG) had higher mortality than those with isolated AI-ECG hyperkalemia (false-positive AI-ECG). Conclusions: AI-ECG probability of hyperkalemia, even with a normal laboratory K, was associated with higher short-term and long-term mortality in CICU patients. The laboratory K value and AI-ECG probability of hyperkalemia are complementary risk factors. The AI algorithm can detect prognostically important ECG abnormalities which may reflect the effects of K levels on the myocardium.
Abstract 15441: Impact of the COVID-19 Pandemic on Cardiac Implantable Electronic Device Procedures and Complications in the United States
Carver, Caleb , Ramphul, Kamleshun , Obeng‐Gyimah, Edmond, Schuler, Brian, Sawatari, Hiroyuki , Wafa, Syed Emir Irfan , Padmanabhan, Deepak , Deshpande, Saurabh , Khan, Hassan , Ahmed, Raheel , Khanji, Mohammed Y , Somers, Virend K. , Providência, Rui , Chahal, C. Anwar A.

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.15441 Get It

Introduction: The impact of COVID-19 was felt across cardiology as resources were redirected to critical care, delaying elective cardiology procedures. Hypothesis: To evaluate differences in outcomes of cardiac implantable electronic device (CIED) procedures in 2020 (height of COVID) vs. 2016-2019 (pre-COVID). Methods: Adults >= 18 years undergoing CIED procedures were identified from National Inpatient Sample Databases (NIS) 2016-2020. Complications and mortality were assessed based on the type of device: Permanent Pacemaker (PPM); Implantable Cardioverter Defibrillator (ICD); Cardiac Resynchronization Therapy with Pacemaker (CRT-P) or defibrillator (CRT-D): Leadless PPM; Generator explant (GE), and Lead extraction (LE). Results: A 13.8% drop in CIED admissions was recorded between 2019 and 2020 (p<0.01). Fewer procedures involving PPM, ICD, CRT-P, CRT-D, LE, and GE were observed between 2019 and 2020. Leadless PPM utilization rose consistently between 2016-2020 (47.6% increase during 2020 vs 2019)(Figure). In 2020, a higher proportion of patients were classified with a Charlson Comorbidity Index score of ≥3 (severe) (47.4% in 2020 vs. 42.9% in 2016-2019, p<0.01). The table shows significantly higher complications during CIED implants with no changes in mortality related to procedures. Conclusions: Patients admitted for CIED implants in 2020 had more severe comorbidities and expressed considerable differences in complications than pre-COVID era (2016-2019), but mortality remained unchanged. Leadless PPM use increased during pandemic, as against a decrease in the use of other CIEDs.
Abstract 15432: Racial and Sex Disparities in Age-Adjusted Mortality in COVID-19 Patients With Atrial Fibrillation in the United States
Carver, Caleb , Ramphul, Kamleshun , Salloum, Mohammad N. , Obeng‐Gyimah, Edmond, Schuler, Brian, Wafa, Syed Emir Irfan , Padmanabhan, Deepak , Deshpande, Saurabh , Khan, Hassan , Ahmed, Raheel , Agboola, Olayinka, Khanji, Mohammed Y , Sawatari, Hiroyuki , Somers, Virend K. , Providência, Rui , Chahal, C. Anwar A.

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.15432 Get It

Introduction: While Coronavirus disease 2019 (COVID-19) primarily affects the respiratory system but can impact the cardiovascular system can triggering various complications. Hypothesis: To investigate the trend in age-adjusted mortality rates (AAMRs) in patients with atrial fibrillation(AF) among COVID-19-positive patients (CPP) by race and sex. Methods: Trends in AAMRs (per 100,000) from all-cause in patients with AF between April to December 2016-2020 were evaluated via the National Inpatient Sample and the US Census Bureau. The AAMRs among CPP with AF in 2020 was also evaluated between racial and sex cohorts. Results: A gradual rise in AAMR(all causes) in patients with AF was observed between 2016-2019, with a 49.4% overall rise between 2019(271 per 100,000) and 2020(405 per 100,000) ( Table 1a and Figure ). Around 250475 COVID-19-positive patients had AF, and 24.2% of cases did not survive their hospitalization (vs. 10.9% in those without AF, p<0.01, aOR 1.457, 95% CI 1.438-1.477). Among CPP males and females with AF that died, White females and males were the oldest, while Black males and females reported the highest mean Charlson Comorbidity Index (CCI) score ( Table 1b ).Furthermore, among the CPP with AF in 2020, Hispanics reported a higher AAMR (119.6 per 100,000) than Whites(111.1 per 100,000) and Blacks(101.9 per 100,000). AAMRs in males were higher in Hispanic males (144.8 per 100,000), followed by White males (129.7 per 100,000), and Black males (110 per 100,000). However, the AAMRs in females were highest in Black females (91.3 per 100,000), followed by White females (88.3 per 100,000) and Hispanic females (87.0 per 100,000). ( Table 1c ) Conclusions: AAMRs in patients with AF are on the rise and a sharp growth was seen during the first year of the pandemic. AAMRs among CPP patients with AF were highest among Black females and Hispanic males, while White males and females were oldest and Black males and females reported the highest CCI scores.
Abstract 15419: Adiponectin’s Predictive Role in Long-Term Mortality and Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease: A Meta-Analysis of Prospective Studies
Jitta, Sahas Reddy , Vatsavayi, Priyanka , Tera, Chenna Reddy, Krishnamurthy, Shobana, Jala, Saisree Reddy Adla, Pasnoor, Diksha Sanjana , Dasari, Utheja, Farooq, Aisha, Maramreddy, Supriya, JAMMULA, KAVYA, Reddy, Medha, Tripuraneni, Sridevi, Desai, Rupak

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.15419 Get It

INTRODUCTION: The relentless toll of cardiovascular disease in the United States demands a breakthrough in reliable and cost-effective prognostic markers. Amidst the limited knowledge surrounding the role of adiponectin in stable coronary artery disease (CAD), this study aims to unveil its power in predicting all-cause mortality and major adverse cardiovascular events (MACE) among patients with stable coronary artery disease (CAD). METHODS: We systematically screened PubMed, Scopus, and Google Scholar for articles until May 2023 to identify relevant studies. Random-effects model estimated the pooled odds ratio (OR) with 95% confidence intervals (CI), and I2 statistics assessed heterogeneity. The leave-one-out method was used for sensitivity analysis. RESULTS: Following the screening, five prospective studies involving 3225 patients with a median follow-up duration of 3.8 years were included. In the study population, hypertension, diabetes, hyperlipidemia, and smoking were prevalent risk factors, and common medications included angiotensin-converting enzyme inhibitors, beta-blockers, and statins. The pooled adjusted OR for all-cause mortality was 2.51 (95%CI: 1.36-4.62), with moderate heterogeneity (I2=65.51%, p=0.03), and the pooled adjusted OR for MACE was 1.04 (95%CI: 1.02-1.06), with no significant heterogeneity (I2=0%, p=0.68) (Fig. 1) . The leave-one-out sensitivity analysis showed that no single study significantly influenced the meta-analysis results, indicating robustness. CONCLUSION: Higher adiponectin levels were associated with higher odds of long-term mortality and MACE in stable CAD patients, highlighting its potential as a cost-effective marker for risk stratification and guiding management strategies. Further studies exploring the role of adiponectin can significantly impact clinical decision-making and resource allocation in cardiovascular care.
Abstract 15372: The Lewis Lead
Elhadi, Mohamed , Killu, Ammar M. , Adel, Fadi

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.15372 Get It

The Lewis lead is a modified ECG configuration that can enhance the amplitude of the atrial electrical activity and is useful when the atrial activity cannot be discerned in the standard ECG. The configuration involves applying the right arm electrode on the manubrium, left arm electrode to the 5th intercostal space on the right sternal border, left leg electrode over the right lower costal margin and right leg electrode in the standard position. The ECG is then interpreted in lead I and II. Herein we present a case where the Lewis lead aided in the diagnosis of complete heart block with underlying atrial fibrillation. Case Presentation: A 75 year old female with severe tricuspid regurgitation was admitted for tricuspid valve replacement. She had previous paroxysmal atrial fibrillation status post pulmonary vein isolation. The preoperative ECG revealed normal sinus rhythm. Postoperatively, ECG demonstrated a narrow complex ventricular rhythm at 70 beats per minute. No atrial activity could be clearly discerned (Image 1). The epicardial atrial wire placed intraoperatively was not functioning, therefore atrial electrogram could not be obtained. It was unclear from repeat ECGs if there was sinus arrest or atrial fibrillation in the atria. The Lewis lead was then utilized and revealed underlying atrial fibrillation (Image 1); together, this was consistent with atrial fibrillation and complete heart block with a junctional escape rhythm. The rhythm did not recover and there was progressive conduction system disease with widening of the QRS and episodes of severe bradycardia. She underwent pacemaker implantation. Discussion: By utilizing the Lewis lead we were able to establish the atrial rhythm and differentiate between atrial fibrillation and sinus arrest. The Lewis lead can also help narrow the differential for wide complex tachycardia by magnifying the p wave, thus making it easier to detect ventriculoatrial dissociation, a hallmark feature of ventricular tachycardia.